Vaccine Therapy in Curative Resected Prostate Cancer Patients
NCT01197625
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
Dendritic cell vaccine
Sponsor
Oslo University Hospital